These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 1331389

  • 1. Calcium therapy for calcitriol-resistant rickets.
    Hochberg Z, Tiosano D, Even L.
    J Pediatr; 1992 Nov; 121(5 Pt 1):803-8. PubMed ID: 1331389
    [Abstract] [Full Text] [Related]

  • 2. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).
    al-Aqeel A, Ozand P, Sobki S, Sewairi W, Marx S.
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):229-37. PubMed ID: 8396512
    [Abstract] [Full Text] [Related]

  • 3. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK.
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Early diagnosis and early treatment of hypophosphatemic vitamin D-resistant rickets].
    Schaumberger E, Hohenauer L, Sommer R.
    Klin Padiatr; 1986 Jun; 198(1):44-8. PubMed ID: 3007858
    [Abstract] [Full Text] [Related]

  • 7. Calcitriol treatment in vitamin D-dependent and vitamin D-resistant rickets.
    Glorieux FH.
    Metabolism; 1990 Apr; 39(4 Suppl 1):10-2. PubMed ID: 2157942
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone therapy in hypophosphatemic rickets.
    Wilson DM, Lee PD, Morris AH, Reiter EO, Gertner JM, Marcus R, Quarmby VE, Rosenfeld RG.
    Am J Dis Child; 1991 Oct; 145(10):1165-70. PubMed ID: 1928011
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.
    Balsan S, Garabedian M.
    J Clin Invest; 1972 Apr; 51(4):749-59. PubMed ID: 4335443
    [Abstract] [Full Text] [Related]

  • 11. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
    Saggese G, Baroncelli GI, Bertelloni S, Perri G.
    J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment with 1,25-dihydroxycholecalciferol in children with different types of resistant rickets].
    Eggers M, Beas F.
    Rev Chil Pediatr; 1982 Sep; 53(2):95-101. PubMed ID: 6294757
    [No Abstract] [Full Text] [Related]

  • 16. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.
    Rivkees SA, el-Hajj-Fuleihan G, Brown EM, Crawford JD.
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1514-8. PubMed ID: 1464657
    [Abstract] [Full Text] [Related]

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D.
    Balsan S, Garabédian M, Larchet M, Gorski AM, Cournot G, Tau C, Bourdeau A, Silve C, Ricour C.
    J Clin Invest; 1986 May; 77(5):1661-7. PubMed ID: 3009551
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.